It has been shown that CCR5 signaling and the CCR5/RANTES axis in breast cancer is more upregulated in patients with more aggressive disease subtypes, though this upregulation is not commonly seen in primary breast tissue but rather in secondary sites (Additional file 1: Fig. S7) [2]. Here, CCR5 is linked to breast cancer.